19 Facts About Joseph Fuisz

Joseph Fuisz is an American attorney, inventor, and entrepreneur of Slovenian descent.

Joseph Fuisz has been involved in the development of drug delivery and the approval of new drugs and low emission tobacco products.

Joseph Fuisz is a named inventor of the formulation of the drug Suboxone.

Joseph Fuisz is the son of Richard Fuisz and Patricia Fuisz.

Joseph Fuisz graduated from Yale University and Columbia Law School.

Joseph Fuisz began his career in law, after graduating from Columbia University Law School.

Joseph Fuisz subsequently moved into medical patents, a field his father Richard Fuisz had worked in for a number of years.

Kosmos Pharma Limited was acquired by MonoSol LLC in 2004, with Joseph Fuisz becoming MonoSol's Senior Vice President.

Joseph Fuisz eventually moved back to Fuisz LLC, concentrating on drug delivery patents.

Joseph Fuisz is a named inventor in the Orange Book for the drug, Suboxone.

Joseph Fuisz became the Managing Director of the company in 2008.

Joseph Fuisz claimed improved nicotine absorption from tobacco in this format.

Joseph Fuisz has developed new tablet shapes that allow for improved esophageal transit.

Joseph Fuisz represented himself pro se in the Theranos case.

Joseph Fuisz discussed this litigation with various media outlets, including ABC's podcast series, The Drop Out.

In recent years, Joseph Fuisz has obtained new drug delivery patents related to new methods of manufacturing thin films for Thin-film drug delivery.

In 2020, Joseph Fuisz announced a new venture, Nova thin Films, based on patents obtained by Richard Fuisz and Joseph Fuisz to make pharmaceutical films by deposit.

Joseph Fuisz recently announced the issuance of patents related to heat not burn tobacco compositions.

Mr Joseph Fuisz received two patents relating to heat-not-burn heating systems in August, 2021.